Clinical Trials Directory

Trials / Completed

CompletedNCT04632576

Acupoint Stimulation and Postoperative Sleep

Effect of Transcutaneous Electrical Acupoint Stimulation on Sleeping After General Anesthesia in Gynecological Laparoscopic Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
274 (actual)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Sleeping model can be affected after surgery. Anesthetics may be involved in the change. The changing of sleeping mode may exert adverse effect on postoperative recovery. Acupuncture and related techniques has been used for treating sleeping disorder. In this study, the effect of transcutaneous electrical acupoint stimulation on sleeping model after general anesthesia will be observed.

Detailed description

Sleep is a necessary, naturally occurring physiologic state that is especially critical to cognition and physical functioning in surgical settings.Poor postoperative sleep is associated with many significant deleterious effects. Therefore, improving overall sleep during postoperative rehabilitation is desirable. Transcutaneous electrical acupoint stimulation (TEAS) is a non-invasive acupuncture therapy combining the transcutaneous electrical nerve stimulation, and has been utilized in clinical settings for many years. Previous study demonstrated that TEAS combined with anesthesia can upregulate the levels of melatonin and aminobutyric acid to relief central inhibition, thus improve patients'sleep efficiency, prolong total sleep time (TST) and promote sleep quality. The current study is to examine the effect of perioperative TEAS on subjective and objective sleep quality among patients who have undergone Gynecological laparoscopic surgery under general anesthesia.

Conditions

Interventions

TypeNameDescription
OTHERtranscutaneous electrical acupoint stimulationElectrodes will be attached on the surface of acupoints and electrical stimulation will given.

Timeline

Start date
2023-06-02
Primary completion
2024-01-23
Completion
2024-01-28
First posted
2020-11-17
Last updated
2024-04-17

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04632576. Inclusion in this directory is not an endorsement.